Business Context and Reporting Period
Company: Argan, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: January 31, 2011
Business Overview: Argan is a holding company operating through two primary subsidiaries: Gemma Power Systems, LLC (GPS), providing engineering and construction services for power generation and renewable energy; and Southern Maryland Cable, Inc. (SMC), providing telecommunications infrastructure services. The company also disposed of its nutritional products segment (Vitarich Laboratories, Inc.) in March 2011, classifying it as discontinued operations.
Key Financial Metrics
| Metric | Fiscal Year 2011 | Fiscal Year 2010 |
|---|---|---|
| Net Revenues (Continuing Ops) | $182.6 million | $218.3 million |
| Gross Profit | $29.1 million (15.9% margin) | $22.7 million (10.4% margin) |
| Income from Continuing Operations | $10.0 million | $8.3 million |
| Net Income | $7.8 million | $7.0 million |
| Diluted EPS (Continuing Ops) | $0.73 | $0.60 |
| Cash and Cash Equivalents | $83.3 million | $66.2 million |
| Working Capital | $73.2 million | $63.4 million |
| Long-Term Debt | $0 (Repaid) | $1.8 million (Current portion) |
| EBITDA (Non-GAAP) | $18.1 million | $14.0 million |
Material Changes vs. Prior Period
- Revenue Decline: Consolidated net revenues decreased 16.4% to $182.6 million, primarily driven by a 16.6% drop in GPS revenues as a major California power plant project moved into the commissioning phase.
- Margin Expansion: Despite lower revenue, gross profit increased by $6.4 million (28.2%) to $29.1 million. The gross margin improved from 10.4% to 15.9% due to a favorable mix of projects and the completion of lower-margin work.
- Profitability Increase: Income from continuing operations rose 20.5% to $10.0 million, aided by improved margins and the absence of non-cash equity earnings from an unconsolidated subsidiary (GRP) that was fully consolidated in the prior year.
- Debt Reduction: The company repaid its remaining term debt of approximately $1.8 million during the fiscal year, resulting in zero long-term debt outstanding as of January 31, 2011.
- Cash Flow Improvement: Net cash provided by continuing operating activities turned positive at $22.2 million, compared to a use of cash of $10.7 million in the prior year.
Guidance, Outlook, and Risks
Outlook and Management Commentary
- Backlog: Contract backlog stood at $291 million at year-end, down slightly from $300 million. Significant projects include a $220 million peaking plant in Southern California (expected to commence Q2 2012) and a $56 million peaking plant in Connecticut.
- Market Conditions: Management notes a weak economic recovery and tight credit markets may delay new project financing. However, they remain cautiously optimistic about long-term growth in gas-fired and renewable energy sectors.
- Discontinued Operations: The sale of Vitarich Laboratories was completed in March 2011 for up to $3.1 million. The company expects a loss from discontinued operations in the range of $700,000 to income of $300,000 for the fiscal year ending January 31, 2012.
Risks and Contingencies
- Customer Concentration: GPS is highly dependent on a few large customers. In 2011, one customer (Pacific Gas & Electric) accounted for 56% of consolidated revenues. Loss of such contracts could materially impact results.
- Legal Proceedings:
- Delta-T Matters: A subcontractor has a $6.8 million judgment against a payment bond issued on behalf of GPS. No provision has been recorded, but a material loss is reasonably possible.
- Tampa Bay Nutraceutical: A lawsuit alleging damages in excess of $42 million against the former VLI subsidiary is ongoing. Management believes it has meritorious defenses but cannot estimate potential damages.
- Debt Covenants: The company has a revolving credit facility with Bank of America subject to financial covenants (e.g., debt-to-EBITDA ratios). While currently compliant, failure to meet these could trigger acceleration of debt.
Investor Verification Checklist
- Customer Concentration Risk: Verify the status of the contract with Pacific Gas & Electric, which represented over half of the company's revenue.
- Legal Exposure: Monitor the resolution of the Delta-T subcontractor dispute ($6.8 million) and the Tampa Bay Nutraceutical litigation ($42 million claim).
- Backlog Realization: Confirm the start date for the $220 million Southern California peaking plant project, which is critical for future revenue recognition.
- Debt Covenants: Review quarterly compliance with Bank of America covenants, specifically the fixed charge coverage and debt-to-EBITDA ratios.
- Discontinued Operations: Track the final settlement of the Vitarich Laboratories sale and the release of escrow funds.